Omeprazole Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-03　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 7.4 Bn
2033 年預估規模: USD 9.67 Bn
年複合成長率 CAGR: 3.9%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-06-03頁數 250報告編號 CMI2380

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Omeprazole Market, By Dosage Form (Capsule, Powder, and Tablet), By Indication (Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease (GERD), Erosive Esophagitis, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Omeprazole delayed-release capsules in combination with other medications are used to eliminate H. pylori, a bacteria causing ulcers and prevent the development of new ulcers in people with a history of ulcer formation of the small intestine. Prescription omeprazole is also used to treat higher acid producing stomach conditions such as Zollinger-Ellison syndrome in adults. According to the survey by Clinical Gastroenterology and Hepatology, 2012, ZES occurs in about one in every 1 million people, and is more common among men 30 to 50 years old. Market Dynamics Increasing prevalence of acid related diseases (ARDs) including gastroesophageal reflux disease (GERD) is a major factor driving omeprazole market growth. According to the research survey conducted by Florida Hospitals, 2015, pregnant women are at a higher risk of acid reflux, with an estimated 25% pregnant women experiencing the symptoms. The survey further stated that about 20% of people with acid reflux are at a higher risk of developing gastroesophageal reflux disease (GERD). Furthermore, increase in H.pylori infection and NSAID associated gastric and duodenal ulcers are expected to bolster market growth in the near future. Also, launch of low-cost generic versions of omeprazole is expected to fuel market growth. For instance, in 2016, Dr. Reddy’s launched generic version to Zegerid capsules (omeprazole/sodium bicarbonate) for short-term treatment of stomach and duodenal ulcers, erosive esophagitis and heartburn associated with gastroesophageal reflux disease (GERD). Key features of the study • This report provides in-depth analysis of the omeprazole market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025, as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players • It profiles key players in the global omeprazole market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include, Astrazeneca Plc., Sandoz, Inc., Mylan N.V., Apotex, Inc., Dr. Reddy’s Laboratories, Inc., Impax Laboratories, Inc., Perrigo Company Plc., Santarus, Inc., Watson laboratories, Inc., and Lek Pharmaceuticals d.d. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global omeprazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the omeprazole market Market Segmentation • By Dosage Form (Revenue, USD Bn, 2021-2033) o Capsule o Powder o Tablet • By Indication (Revenue, USD Bn, 2021-2033) o Duodenal Ulcer o Gastric Ulcer o Gastroesophageal Reflux Disease (GERD) o Erosive Esophagitis o Others • By Distribution Channel (Revenue, USD Bn, 2021-2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Astrazeneca Plc. o Sandoz, Inc. o Mylan N.V. o Apotex, Inc. o Reddy’s Laboratories, Inc. o Impax Laboratories, Inc. o Perrigo Company Plc o Santarus, Inc. o Watson laboratories, Inc. o Lek Pharmaceuticals d.d.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Dosage Form  Market Snapshot, By Indication  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Product Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Omeprazole Market, By Dosage Form, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Capsule  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Powder  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Tablet  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 5. Global Omeprazole Market, By Indication, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Duodenal Ulcer  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Gastric Ulcer  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Gastroesophageal Reflux Disease (GERD)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Erosive Esophagitis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 6. Global Omeprazole Market, By Distribution Channel, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 7. Global Omeprazole Market, By Region, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Astrazeneca Plc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Sandoz, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Mylan N.V. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Apotex, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Dr. Reddy’s Laboratories Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Impax laboratories, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Perrigo Company Plc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Santarus, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Watson Laboratories, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Lek Pharmaceuticals d.d. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 9. Section o References o Research Methodology o About Us

提及公司

Astrazeneca Plc.Sandoz, Inc.Mylan N.V.Apotex, Inc.Reddy’s Laboratories, Inc.Impax Laboratories, Inc.Perrigo Company PlcSantarus, Inc.Watson laboratories, Inc.Lek Pharmaceuticals d.d.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們